BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAF8. A total of 39 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $446,000 | -9.0% | 430,000 | 0.0% | 0.33% | -27.4% |
Q2 2019 | $490,000 | -2.6% | 430,000 | -2.3% | 0.46% | +43.7% |
Q1 2019 | $503,000 | -1.9% | 440,000 | -4.3% | 0.32% | -20.3% |
Q4 2018 | $513,000 | -12.3% | 460,000 | -5.2% | 0.40% | +1.5% |
Q3 2018 | $585,000 | -9.6% | 485,000 | -11.0% | 0.39% | +12.0% |
Q2 2018 | $647,000 | +165.2% | 545,000 | +147.7% | 0.35% | +123.6% |
Q1 2018 | $244,000 | +577.8% | 220,000 | +633.3% | 0.16% | +528.0% |
Q4 2017 | $36,000 | – | 30,000 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Birch Grove Capital LP | 5,950,000 | $6,146,000 | 4.56% |
ADVENT CAPITAL MANAGEMENT /DE/ | 37,943,000 | $39,192,000 | 0.73% |
Sonora Investment Management, LLC | 4,670,000 | $4,791,000 | 0.50% |
MIZUHO SECURITIES USA LLC | 5,900,000 | $6,096,000 | 0.36% |
IRON Financial LLC | 430,000 | $446,000 | 0.33% |
RWC Asset Management LLP | 7,300,000 | $7,528,000 | 0.32% |
Calamos Advisors LLC | 49,525,000 | $51,243,000 | 0.28% |
EDMOND DE ROTHSCHILD HOLDING S.A. | 5,777,000 | $5,977,000 | 0.24% |
PALISADE CAPITAL MANAGEMENT, LP | 5,721,000 | $5,896,000 | 0.18% |
Calamos Wealth Management LLC | 1,240,000 | $1,283,000 | 0.17% |